Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. - Wikidata - wikimedia - TriplyDB

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

http://www.wikidata.org/entity/Q34553777

about

The prediagnostic phase of Parkinson's disease The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.The role of biomarkers and imaging in Parkinson's disease.Neuroimaging in pre-motor Parkinson's disease Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Depiction of dentatorubrothalamic tract fibers in patients with Parkinson's disease and multiple sclerosis in deep brain stimulation.Blood biomarker for Parkinson disease: peptoids.Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease The predictive value of SS-16 in clinically diagnosed Parkinson's disease patients: comparison with (99m)Tc-TRODAT-1 SPECT scans.PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.Recognition and treatment of autonomic disturbances in Parkinson's disease.The relevance of pre-motor symptoms in Parkinson's disease.The Concept of Prodromal Parkinson's Disease.Review: The spectrum of clinical features seen with alpha synuclein pathology.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.Biomarkers in Prodromal Parkinson Disease: a Qualitative Review.Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere.Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.Subtle motor disturbances in PREDICT-PD participants.Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Exploring white matter microstructure and olfaction dysfunction in early parkinson disease: diffusion MRI reveals new insight.Update on Molecular Imaging in Parkinson's Disease.Cognition and the course of prodromal Parkinson's disease.Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson's Disease.Parkinson disease: How reliable are prodromal indicators of Parkinson disease?Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort.Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?

P2860

Q26768732-061B1033-0104-4E03-B1FB-4E2686B8ABB2 Q30635471-9E574398-8957-4A29-8530-82F0C2E77301 Q31041660-B815BC10-2144-4E99-9F9C-6D6882DB1B92 Q33676222-C380A6A1-A033-4948-8635-C506756EE3CF Q33731267-70D80F71-BED4-45EE-9CFD-F3834A0DE1C9 Q36081068-245E8ADA-F8D4-477D-9357-B2139ACEAFBE Q36182485-F5E0509A-8422-4372-BCD5-24618A88E121 Q36785957-9D452923-08AF-47C9-A6A1-7597B60F788E Q36891717-7D0CD18D-BABC-4E05-8D8F-E97CC746C386 Q37054007-33EBF964-3C5C-488F-97E4-671B757DBFE5 Q37121555-B74EA7B5-56DF-450A-A3B7-8E0EFE4683CB Q37192609-17D43AB4-6193-48D6-9911-BFA151F0C77E Q37663889-4035097F-3F1A-45B0-9F12-D29E372C1CD9 Q37693339-5A4B823F-A3C7-4717-BA65-263C6368D705 Q38492560-4030D13B-8FCF-4C08-80AD-8EAB01F1C96F Q38594855-4A50E29A-58D4-4DA3-8BD8-A7EB15720ADA Q38594857-D6081FF4-D004-4902-94F3-EB1295DBEB4E Q38612230-685175F7-0BED-4717-8701-A92D19AAE16B Q38691823-728F9D4F-BA70-443C-8927-7A7AE74757F2 Q38752945-F3F46DF1-1ABA-4AA7-A70D-EE3BB7F06F01 Q38779931-32EFA011-AEA9-42C5-9E4A-BEE2ECF2D820 Q38788917-6248BDA1-BE6D-495B-96F9-1A462B76BA19 Q38998616-5FDDC464-39BB-4563-9531-2F902C348AB1 Q39329635-890D765E-E8C4-455D-8670-9245C1294829 Q40041644-4A4E2D3E-F3EC-4931-A121-0B7E264E6728 Q41143619-211FCD1D-D625-4869-B828-B3F6C3548204 Q42488643-A8646E86-C778-4A3A-B709-91362A1BC770 Q46354756-615D676B-CAC3-4407-98E1-10D76C33A5CB Q47218321-05E255A7-9C16-4C08-B664-3594A3CC9046 Q47250613-E0800BDB-292D-4F96-AB41-BAFA164645D7 Q47730444-C569DEBB-9A8F-4BF5-A861-2894E37943D6 Q47730775-D18E0675-1A4B-4633-8E7F-8624DC12F65B Q47943502-A3B3B9F3-E191-436B-9112-7F7BFD46A05B Q48007729-6C277B10-1730-4186-A711-52D3C1279F07 Q48129130-C6A5D1CD-AA27-4424-8BF5-3262902BE5A4 Q50566330-C0700DE3-3E37-478B-B2F7-A56F9F7BBFC9 Q50953428-0A17E5DF-DDCD-4982-8B2D-DA74E25CC6ED Q57142239-9E73AFCF-2C8B-4338-9FD2-FEC02FC25DEC Q58585963-14C4D8AE-A46C-476B-85AB-6B836B26EED3

P2860

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

http://www.wikidata.org/entity/Q34553777

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@ast

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@en

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@nl

type

label

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@ast

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@en

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@nl

prefLabel

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@ast

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@en

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@nl

P1433

Q34553777-97164DF2-A731-4DB1-811E-0BEF230B8ECA

P1476

Q34553777-619D7E0A-F6CE-42BE-9646-676201D0B007

P2093

Q34553777-1FAC2405-56DB-4E78-933F-0AB9B042D2F6

Q34553777-347A3F5D-9A96-4F41-8EBA-B2ACC4D16697

Q34553777-742D9DA6-E3AA-4C73-8E6B-C7B032EC773F

Q34553777-8740F5E2-4704-4900-AFE8-38C63F7C6CE4

Q34553777-9885A4EB-070A-4A5E-9715-B261944B2EB8

Q34553777-D32335AE-013D-4275-8CF1-3E622F126EDE

Q34553777-E7846E93-A055-48E7-B150-502ADBF6D001

P2860

Q34553777-0023FBBB-3DB9-4178-B11B-39B4CF461363

Q34553777-02D90950-8AEE-46CD-A81B-589D63AE789B

Q34553777-16C03B3D-4AA6-413E-B0DC-697F90BACFE8

Q34553777-24AD73D1-0B74-4BB9-B2F7-D477B3B7941A

Q34553777-3B530F40-7D10-4203-A581-5ADC5D9DA42D

Q34553777-4C634BAB-2D50-4D19-8605-57BB93220003

Q34553777-52E28660-78B2-433E-A3B2-DBE8A0E1714F

Q34553777-579984AB-B672-4B89-AA80-FB0DEE8B1894

Q34553777-5AC8B2F1-0B18-4D54-B0F3-8A10ECABBFD7

Q34553777-5B8D8E68-4E56-47EB-8055-F1BC015F5588

P304

Q34553777-7BCF5442-D443-4D0F-B043-264FBD535788

P31

Q34553777-25FA1D09-5C6F-453C-BDD7-DF2CBA6A9F70

P356

Q34553777-61FAA93A-B93F-4ED0-B442-E3801BFDB204

P407

Q34553777-BA853903-5502-45B7-9769-F4D30CE2F2F8

P433

Q34553777-715B3478-931A-49C4-8EAD-B50F139AD696

P478

Q34553777-E831478E-14BD-42E6-8B08-FC510DAC5CBD

P50

Q34553777-EEC3C175-3092-49AA-AEBC-6C3F026740E0

P577

Q34553777-DF6734B0-D480-4A05-894D-6A2E5C8932BB

P698

Q34553777-E132420A-AA22-4D8E-883A-FCC80499C94A

P921

Q34553777-EAFD4B92-7924-49B3-B995-299A6BDB2C36

P932

Q34553777-22526E03-B60D-4356-92C1-41E94E1861B6

P356

WNL.0000000000000960

P1433

P1476

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.

@en

P2093

Danna Jennings

http://www.w3.org/2001/XMLSchema#string

David Oakes

http://www.w3.org/2001/XMLSchema#string

John Seibyl

http://www.w3.org/2001/XMLSchema#string

Kenneth Marek

http://www.w3.org/2001/XMLSchema#string

Matthew Stern

http://www.w3.org/2001/XMLSchema#string

PARS Investigators

http://www.w3.org/2001/XMLSchema#string

Shirley Eberly

http://www.w3.org/2001/XMLSchema#string

P2860

Staging of brain pathology related to sporadic Parkinson's disease

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

Frequency of bowel movements and the future risk of Parkinson's disease.

Bowel movement frequency in late-life and substantia nigra neuron density at death

Longitudinal follow-up of SWEDD subjects in the PRECEPT Study

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study.

The PRIPS study: screening battery for subjects at risk for Parkinson's disease.

Levodopa and the progression of Parkinson's disease.

Diagnostic staging of Parkinson's disease: conceptual aspects.

P304

1739-1746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000000960

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Siderowf

P577

2014-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25298306

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4239830

http://www.w3.org/2001/XMLSchema#string